Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Lynk Pharmaceuticals Completes Series C2 Financing Round, with Total C Round Funding of 322 Million RMB 2023-09-21 08:00
Everest Medicines Enters into Collaboration and License Agreement with Kezar Life Sciences to Develop and Commercialize Zetomipzomib in Greater China and other Asian Markets 2023-09-21 07:05
Diana Bracco: "Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses" 2023-09-21 01:47
European Commission Approves Menarini Group's ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation 2023-09-20 23:27
Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies 2023-09-20 20:00
Double Honors: Sanyou Bio Earns "Most Trusted Biopharmaceutical CXO Partner" and "Most Influential Partner of the Year" Awards 2023-09-20 20:00
Centre for Ion Beam Applications at NUS designated as IAEA's first Collaborating Centre in Singapore 2023-09-20 19:31
The First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint 2023-09-20 15:52
AffaMed Therapeutics Announces First Patient Treated in Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery 2023-09-20 09:00
Everest Medicines Announces China Center for Drug Evaluation of NMPA Recommends Priority Review for Cefepime-Taniborbactam for the Treatment of Complicated Urinary Tract Infections, including Pyelonephritis 2023-09-20 08:26
Angel Group's First Industrialized Strain of Probiotics Anchors Strategic Transformation Towards Biotechnology 2023-09-19 21:19
Cerecin strengthens position in neurometabolism with addition to pipeline 2023-09-19 19:39
Caliway Announces the Completion of Subject Recruitment in the CBL-0201EFP Phase 2-stage 2 Study Evaluating the CBL-514 in Cellulite Treatment 2023-09-19 11:16
ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility 2023-09-19 09:16
Agilent and NCCS Sign Research Collaboration Agreement to Advance Singapore's Genomic Profiling on Asian-prevalent Cancers 2023-09-19 09:00
Acepodia Announces Nobel Laureate Carolyn Bertozzi, Ph.D., as Chief Scientific Advisor 2023-09-18 19:00
Canton Biologics Completes Over 300 Million Yuan Series C Financing, Led by SDIC Venture Capital 2023-09-18 18:43
Biosyngen received the Asia Pacific Cell & Gene Therapy Excellence Awards (APCGTEA) 2023 2023-09-18 17:53
Broncus Announced Long-Term Follow-Up Data on InterVapor, Showing Stable Long-Term Efficacy in Patients 2023-09-18 17:36
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance 2023-09-18 07:57
1 80 81 82 83 84 452